Hilan Ltd.
Hilan Ltd. (HLTEF) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Hilan Ltd. (HLTEF), covering cash flow, earnings, and balance sheets.
Hilan Ltd. (HLTEF) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Hilan Ltd. HLTEF financial performance.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $782.65M | $764.40M | $694.76M | $670.22M |
| Cost of Revenue | $602.97M | $574.98M | $548.92M | $515.65M |
| Gross Profit | $179.69M | $189.42M | $145.84M | $154.57M |
| Gross Profit Ratio | $0.23 | $0.25 | $0.21 | $0.23 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $90.40M | -$189.33M | $78.94M | $75.43M |
| Operating Expenses | $90.40M | $85.95M | $76.39M | $75.43M |
| Total Costs & Expenses | $693.37M | $660.94M | $625.31M | $591.09M |
| Interest Income | $9.70M | -$4.44M | $4.39M | $5.74M |
| Interest Expense | $12.95M | -$9.32M | $9.94M | $7.74M |
| Depreciation & Amortization | $29.76M | $30.35M | $28.94M | $27.83M |
| EBITDA | $128.35M | $125.73M | $102.31M | $112.12M |
| EBITDA Ratio | $0.16 | $0.16 | $0.15 | $0.17 |
| Operating Income | $89.29M | $103.47M | $69.44M | $79.14M |
| Operating Income Ratio | $0.11 | $0.14 | $0.10 | $0.12 |
| Other Income/Expenses (Net) | -$3.65M | $1.15M | -$6.02M | -$2.58M |
| Income Before Tax | $85.64M | $104.62M | $63.43M | $76.56M |
| Income Before Tax Ratio | $0.11 | $0.14 | $0.09 | $0.11 |
| Income Tax Expense | $19.23M | $23.31M | $14.14M | $17.59M |
| Net Income | $66.15M | $80.86M | $49.08M | $58.74M |
| Net Income Ratio | $0.08 | $0.11 | $0.07 | $0.09 |
| EPS | $2.88 | $3.29 | $2.14 | $2.56 |
| Diluted EPS | $2.85 | $3.26 | $2.12 | $2.53 |
| Weighted Avg Shares Outstanding | $22.97M | $22.93M | $22.93M | $22.94M |
| Weighted Avg Shares Outstanding (Diluted) | $23.21M | $23.15M | $23.15M | $23.22M |
Over the past four quarters, Hilan Ltd. demonstrated steady revenue growth, increasing from $670.22M in Q2 2024 to $782.65M in Q1 2025. Operating income reached $89.29M in Q1 2025, maintaining a consistent 11% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $128.35M, reflecting operational efficiency. Net income dropped to $66.15M, with EPS at $2.88. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan